Ozempic vs Wegovy: They Are the Same Drug — Here Is What Is Actually Different
The Short Answer
Ozempic and Wegovy both contain semaglutide — the exact same molecule. The differences are in FDA-approved indication, approved dose, pen design, and insurance coverage. They are not interchangeable from a prescribing, dosing, or coverage standpoint — even though the active ingredient is identical.
Side-by-Side Comparison
| Ozempic | Wegovy | |
|---|---|---|
| Active ingredient | Semaglutide | Semaglutide |
| FDA-approved for | Type 2 diabetes | Chronic weight management |
| Maintenance dose | 0.5mg, 1mg, or 2mg weekly | 2.4mg weekly |
| Starting dose | 0.25mg weekly | 0.25mg weekly |
| Pen design | Multi-dose pen (4 doses per pen) | Single-dose pen per injection |
| Insurance coverage | Typically covered for T2D | Often not covered; depends on plan |
| Manufacturer | Novo Nordisk | Novo Nordisk |
| List price (approx.) | ~$935/month | ~$1,350/month |
Why the Same Drug Has Two Brand Names
Novo Nordisk developed semaglutide first for type 2 diabetes (Ozempic, approved 2017). When clinical trials showed significant weight loss — the STEP trials demonstrating a mean 14.9% weight loss at 68 weeks — they pursued a separate FDA approval specifically for obesity/weight management at a higher 2.4mg maintenance dose, under the brand name Wegovy (approved June 2021).
(STEP 1 trial: Wilding JPH et al. N Engl J Med. 2021;384:989-1002. PMID: 33567185)
The Dose Difference Matters
Ozempic’s maximum approved dose for diabetes is 2mg weekly. Wegovy’s maintenance dose is 2.4mg weekly. This is not a trivial difference — the higher dose is associated with greater weight loss. The STEP 5 trial showed sustained weight loss at Wegovy’s 2.4mg dose over 104 weeks, with results consistent with the 68-week STEP 1 findings.
(Garvey WT et al. Two-year effects of semaglutide in adults with overweight or obesity. Nat Med. 2022. PMID: 36216945)
Off-Label Use: The Ozempic for Weight Loss Reality
Millions of people have been prescribed Ozempic off-label for weight loss — meaning their doctor prescribed it for a use not on the FDA label. This is legal and common in medicine. However:
- Insurance typically will not cover Ozempic for weight loss (it is labeled for diabetes)
- The dose may be lower than the Wegovy maintenance dose (2.4mg)
- Availability has fluctuated due to supply chain pressures from off-label demand
Which One Should You Ask For?
If you have type 2 diabetes: Ozempic is the FDA-approved, typically insurance-covered option.
If you are seeking weight loss and meet BMI criteria (≥30, or ≥27 with a comorbidity): Wegovy is the appropriate FDA-approved treatment. Insurance coverage is inconsistent but improving.
If Wegovy is unavailable or unaffordable: Discuss with your provider whether Ozempic at an equivalent dose is appropriate — understanding that coverage will likely be out-of-pocket for the weight loss indication.
The Bottom Line
Ozempic and Wegovy are the same drug at different approved doses, for different FDA indications, with different insurance realities. Wegovy’s 2.4mg maintenance dose is the formulation with the most weight-loss efficacy data. If weight management is your goal, Wegovy is the medically appropriate brand to discuss with your provider — though cost and availability often drive what is actually accessible.
Medical Disclaimer: This article is for informational and educational purposes only. It does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or treatment.
📥 Get the 90-Day Companion Guide
Week-by-week milestones, side effect protocols, and a progress tracker for your entire semaglutide journey.
